AVROBIO, Inc.

AVROBIO, Inc.verified

AVRO

Price:

$1.4

Market Cap:

$588.06M

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter ...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

AVRO

The Enterprise Value as of May 2026 (TTM) for AVROBIO, Inc. (AVRO) is 355.80M

According to AVROBIO, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 355.80M. This represents a change of 141.33% compared to the average of 147.43M of the last 4 quarters.

AVROBIO, Inc. (AVRO) Historical Enterprise Value (quarterly & annually)

How has AVRO Enterprise Value performed in the past?

The mean historical Enterprise Value of AVROBIO, Inc. over the last ten years is 321.03M. The current 355.80M Enterprise Value has changed 10.98% with respect to the historical average. Over the past ten years (40 quarters), AVRO's Enterprise Value was at its highest in in the March 2018 quarter at 688.90M. The Enterprise Value was at its lowest in in the March 2022 quarter at -88965615.84.

Quarterly (TTM)
Annual

Average

321.03M

Median

257.24M

Minimum

880.68K

Maximum

741.47M

AVROBIO, Inc. (AVRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AVROBIO, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.97%

Maximum Annual Enterprise Value = 741.47M

Minimum Annual Increase = -99.36%

Minimum Annual Enterprise Value = 880.68K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025129.69M-76.16%
2024543.93M1.42%
202335.86M3.97%
2022880.68K-99.36%
2021137.98M-43.69%
2020245.03M-32.90%
2019365.17M35.52%
2018269.46M-63.63%
2017740.87M-0.08%

AVROBIO, Inc. (AVRO) Average Enterprise Value

How has AVRO Enterprise Value performed in the past?

The current Enterprise Value of AVROBIO, Inc. (AVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

236.49M

5-year avg

169.67M

10-year avg

321.03M

AVROBIO, Inc. (AVRO) Enterprise Value vs. Peers

How is AVRO’s Enterprise Value compared to its peers?

AVROBIO, Inc.’s Enterprise Value is greater than Neuphoria Therapeutics Inc. (9.29M), greater than BiondVax Pharmaceuticals Ltd. (21.44M), greater than Fresh Tracks Therapeutics, Inc. (-5282955.00), greater than Tricida, Inc. (126.38M), greater than Nabriva Therapeutics plc (-7192677.00), greater than Entero Therapeutics, Inc. (21.07M), greater than Longevity Health Holdings Inc. (516.10K), greater than Aptose Biosciences Inc. (3.42M), greater than Gamida Cell Ltd. (40.73M), greater than Xenetic Biosciences, Inc. (-1397743.00),

Build a custom stock screener for AVROBIO, Inc. (AVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AVROBIO, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AVROBIO, Inc. (AVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AVROBIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AVROBIO, Inc.'s Enterprise Value?

What is the highest Enterprise Value for AVROBIO, Inc. (AVRO)?

What is the 3-year average Enterprise Value for AVROBIO, Inc. (AVRO)?

What is the 5-year average Enterprise Value for AVROBIO, Inc. (AVRO)?

How does the current Enterprise Value for AVROBIO, Inc. (AVRO) compare to its historical average?